PDE5 inhibitors in plain terms During arousal, your body releases nitric oxide, which tells smooth muscle to relax
This video walks through dosing, timing, monitoring tips, and practical considerations for safe, effective use
Arnott C, Li JW, Cannon CP, de Zeeuw D, Neuen BL, Heerspink HJL, Charytan DM, Agarwal A, Huffman MD, Figtree GA, et al
One Phase 2 trial of lixisenatide in Parkinsons did meet its primary motor endpoint, the biology of GLP-1 in the brain is real, and questions remain about earlier intervention, specific subpopulations, and whether vascular or metabolic contributions to neurodegeneration might still respond
This ongoing feedback ensures the process stays on track while supporting any necessary lifestyle changes
(1) S Sayeed Ahmad, K Ahmad, E Ju Lee, Y-H Lee, and I Choi (2020) Implications of Insulin-Like Growth Factor-1 in Skeletal Muscle and Various Diseases Cells, 2020 Jul 24, Volume 9 (Issue 8), Page 1773